Mark Turner
Mark Turner is a Neonatologist and European Co-Director of the International Neonatal Consortium who has been instrumental in setting up five international paediatric research collaborations involving academia, regulators, industry, and families. He co-leads the largest ever European public-private partnership in paediatric research ($155 million Innovative Medicines Initiative 2 project, “conect4children”) with responsibility for the processes of this pan-European paediatric clinical trials network. As CI, PI and medical expert in publicly funded and industry evaluations of 16 active pharmaceutical ingredients and three excipients he has extensive experience of protocol design and implementation (including Paediatric Investigation Plans). He is currently President of the European Society of Developmental Perinatal and Paediatric Pharmacology.
